Literature DB >> 15081019

Synthesis and anti-HCMV activity of 1-acyl-beta-lactams and 1-acylazetidines derived from phenylalanine.

Guillermo Gerona-Navarro1, M Jesús Pérez de Vega, M Teresa García-López, Graciela Andrei, Robert Snoeck, Jan Balzarini, Erik De Clercq, Rosario González-Muñiz.   

Abstract

Different Phe-derived 1-acyl-beta-lactams, analogous to a series of 2-azetidinones acting as HCMV serine protease inhibitors, were synthesized. Some of these compounds were modest inhibitors of the HCMV replication. Interestingly, removal of the carbonyl group of the beta-lactam ring, most likely acting as the serine trap, resulted in an azetidine derivative with anti-HCMV activity comparable to that of the reference compound ganciclovir.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15081019     DOI: 10.1016/j.bmcl.2004.02.010

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

1.  Novel yeast cell-based assay to screen for inhibitors of human cytomegalovirus protease in a high-throughput format.

Authors:  Valérie Cottier; Alcide Barberis; Urs Lüthi
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 2.  Current and potential treatments for ubiquitous but neglected herpesvirus infections.

Authors:  Jonathan E Gable; Timothy M Acker; Charles S Craik
Journal:  Chem Rev       Date:  2014-10-02       Impact factor: 60.622

3.  Synthesis of novel N-sulfonyl monocyclic beta-lactams as potential antibacterial agents.

Authors:  Aliasghar Jarrahpour; Maaroof Zarei
Journal:  Molecules       Date:  2006-01-31       Impact factor: 4.411

4.  Synthesis and antimicrobial activities of some novel diastereoselective monocyclic cis-β-lactams using 2-ethoxy carbonyl DCPN as a carboxylic acid activator.

Authors:  Mahesh Kumar Mishra; Vedeshwar Narayan Singh; Khursheed Ahmad; Sitaram Sharma
Journal:  Mol Divers       Date:  2020-05-13       Impact factor: 2.943

5.  Crystal structure of 1-(4-meth-oxy-phen-yl)-4-(4-nitro-phen-yl)-3-phen-oxy-azetidin-2-one.

Authors:  Sevim Türktekin Çelikesir; Mehmet Akkurt; Aliasghar Jarrahpour; Habib Allah Shafie; Ömer Çelik
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-01-01

6.  Synthesis and SAR studies on azetidine-containing dipeptides as HCMV inhibitors.

Authors:  Paula Pérez-Faginas; M Teresa Aranda; M Teresa García-López; Robert Snoeck; Graciela Andrei; Jan Balzarini; Rosario González-Muñiz
Journal:  Bioorg Med Chem       Date:  2010-12-30       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.